Skip to content

Effects of a Myofascial Technique on Biomechanical Properties of the Lumbar Myofascia of Chronic Low Back Pain Adults

Effects of a Myofascial Technique on Biomechanical Properties of the Lumbar Paraspinal Muscle and Thoracolumbar Fascia in Chronic Low Back Pain Adults Assessed by Elastography, Ultrasonography and Myometry

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04830566
Enrollment
49
Registered
2021-04-05
Start date
2021-03-19
Completion date
2022-07-15
Last updated
2022-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Low Back Pain

Keywords

Low back pain, Fascia properties, Thoracolumbar fascia, Myofascial release, Manual therapy, Osteopathy, Ultrasound imaging, Sonoelastography

Brief summary

Non-specific low back pain is a worldwide health issue that remains poorly understood. Some authors have shown that the thoracolumbar fascia of low back pain adults presents changes in biomechanical properties. As it is richly endowed with pain receptors, the thoracolumbar fascia could therefore be a key contributor to this chronic pain condition. Myofascial techniques (MFTs) are commonly used in manual therapy by practitioners of various backgrounds to address fascia biomechanical properties, but there is a paucity of objective evidence on their effects on tissue state. Musculoskeletal ultrasonography, sonoelastography and myometry are emerging imaging techniques that can quantify the biomechanical properties of fascia and underlying muscle. These innovative techniques could in turn contribute to a better understanding of MFTs effects on fascial properties. The main objective of this study is to evaluate the immediate effect of a standardized MFT on the elastography features of the lumbar paraspinal muscle and fascia (i.e. myofascial unit). The secondary objectives are to evaluate the immediate effects of a MFT on: i) ultrasonography features of the myofascial unit; ii) myometry features of the myofascial unit; ii) pain intensity.

Interventions

OTHERMyofascial release technique

Myofascial technique on the thoracolumbar fascia and lumbar paraspinal muscles

OTHERSimulated Myofascial Release technique

Superficial hands contact on the lumbar area

Sponsors

Université de Sherbrooke
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adults over 18 years of age, * lumbar pain and/or referred pain above or below the gluteal fold , with intensity \> 3/10, persisting for \> 6 months and presenting during the day \> 50% of the time.

Exclusion criteria

* history of serious spinal or lower extremity injury or surgery in the last year * identifiable back pain or known pathology * known rheumatological condition * oral or injectable corticosteroids in the lumbar spine within the last 3 months * psychiatric disorder * pregnancy * manual treatment of the lumbo-sacral region 1 month prior to the experimentation and during the week of the study

Design outcomes

Primary

MeasureTime frameDescription
Changes in elastography features of the myofascial unitBaseline (before treatment), post-treatment (immediately after treatment)Evaluated with a shear wave sonoelastography device.

Secondary

MeasureTime frameDescription
Changes in ultrasonography features of the myofascial unitBaseline (before treatment) post-treatment (immediately after treatment)Evaluated with a B-mode ultrasound imaging device
Changes in myometry features of the myofascial unitBaseline (before treatment) post-treatment (immediately after treatment)Evaluated with a myotonometer
Changes in pain intensityBaseline (before treatment) post-treatment (immediately after treatment), at day 2 and at day 7 after the interventionNumeric rating Scale (0 to 10; minimum = 0; maximum = 10; higher score means worst outcome)

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026